Tembisa Clinical Research Centre

Experience

The site has conducted:
- 4 TB Treatment Trials (RifaQuin, ReMOXTB, MAMS TB01, NC002).
- 1 TB Vaccine trial (H1/IC31), in an HIV-positive cohort
- Large phase III HIV- prevention trial in HIV-ve females at high risk for acquiring HIV-infection to test the safety and efficacy of a vaginal microbicide in preventing HIV-transmission.

Research interests

HVTN (HIV Vaccine Trial Network), EDCTP (European and Developping Countries Clinical Trials Partnership), IHI (Ifakara Health Institute, Tanzania), TB Alliance, Aeras.

Disease areas

• HIV
• Respiratory Diseases
• Sexually Transmitted Diseases (STDs)
• TB

Media

Documents